Oxford Endovascular
PrivateLast Round
Series A
Extension
May 20, 2024
Total Funding Raised
$27.41M
Company Overview
Oxford Endovascular is a biotechnology company that develops origami-inspired, laser-cut metal alloy medical devices for the treatment of brain aneurysms.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
endovascular deviceflow-diverter stentintracranial aneurysmbrain aneurysm treatmentneurovascular surgeryflow diversionminimally invasive surgeryneurointerventional deviceorigami engineeringmedical implantneurovascular stentstroke caremedtechinterventional neuroradiology
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oxford Endovascular Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Oxford Endovascular Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | May 20, 2024 | ||||
| Series A | Apr 8, 2021 | ||||
| Grant | Nov 16, 2020 | ||||
| Grant | Jul 10, 2020 | ||||
| Grant | Jul 8, 2019 | ||||
Seed | Jan 6, 2016 |
Oxford Endovascular Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| European Commission (Horizon Europe) | Grant |
| Oxford Science Enterprises | Seed, Series A |
| EIT Health | Grant |
| Perivoli Innovations | Series A |
| Vulpes Investment Management | Series A, Series A Extension |
| Oxford Science Enterprises | Series A Extension |
Oxford Endovascular Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Oxford Endovascular's valuation, stock price, and market status.
Firmographic Details
HeadquartersOxford
Employee Range9
Year Founded2015
Last FundingMay 20, 2024